Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Raquel Guardeno Sanchez"'
Autor:
Manish A. Shah, Anghel Adrian Udrea, Igor Bondarenko, Was Mansoor, Raquel Guardeño Sánchez, Tomasz Sarosiek, Silvia Bozzarelli, Michael Schenker, Carlos Gomez-Martin, Carys Morgan, Mustafa Özgüroğlu, Joanna Pikiel, Haralabos P. Kalofonos, Elzbieta Wojcik, Tomas Buchler, Daniel Swinson, Irfan Cicin, Mano Joseph, Ihor Vynnychenko, Alexander Valerievich Luft, Peter C. Enzinger, Tomas Salek, Christos Papandreou, Christophe Tournigand, Evaristo Maiello, Ran Wei, David Ferry, Ling Gao, Joana M. Oliveira, Jaffer A. Ajani
Publikováno v:
Cancers, Vol 14, Iss 5, p 1168 (2022)
Studies JVDB and JVCZ examined alternative ramucirumab dosing regimens as monotherapy or combined with paclitaxel, respectively, in patients with advanced/metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma. For JVDB, randomized patient
Externí odkaz:
https://doaj.org/article/0553a5845acd48c2aeae5976fde4d9de
Autor:
Zev A. Wainberg, Yoon Koo Kang, Raquel Guardeno Sanchez, Steven Smith, Derek Murphy, Siddhartha Mitra, Allie Tappe, Michelle Y. Sun, Peter C. Enzinger, Aaron Q. Xu, Ian Misner, Giovanni Gerardo Cardellino, Daniel V.T. Catenacci
Publikováno v:
Cancer Research. 81:2187-2187
Background: Metastatic GEA is a molecularly heterogeneous disease with limited therapeutic options. It is the third most common cause of cancer death globally. Targeted therapies against HER2 positive and microsatellite instability-high (MSI-H) GEA h